Sfoglia per AUTORE
MERLI F
Collezione AOU Novara
Items : 20
IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma. in Blood advances / Blood Adv. 2024 Mar 26;8(6):1541-1549. doi: 10.1182/bloodadvances.2023011251.
2024
ASL Biella
AO Alessandria
AOU Città della Salute di Torino
AOU Novara
Zucca E; Vitolo U; Pinotti G; Dore F; Esposito F; Pirosa MC; Cesaretti M; Bonomini L; Ghiggi C; Pisani F; Zanni M; Liberati AM; Annibali O; Celli M; Bruna R; Orsucci L; Cabras MG; Tani M; Tucci A; Vanazzi A; Balzarotti M; Merli F; Stathis A; Gaidano G; Sassone M; Botto B; Conconi A; Chiappella A; Ferreri AJM; et alii...
Biological features and outcome of diffuse large B-cell lymphoma associated with hepatitis C virus in elderly patients: Results of the prospective 'Elderly Project' by the Fondazione Italiana Linfomi. in British journal of haematology / Br J Haematol. 2023 May;201(4):653-662. doi: 10.1111/bjh.18678. Epub 2023 Feb 2.
2023
AOU Città della Salute di Torino
AO Alessandria
AOU Novara
Spina M; Tani M; Marino D; Arcaini L; Vallisa D; Usai SV; Chiappella A; Sartori R; Gini G; Flenghi L; Zanni M; Di Rocco A; Cavallo F; Casaluci GM; Tucci A; Puccini B; Pennese E; Fabbri A; Merli M; Zilioli VR; Balzarotti M; Marcheselli L; Merli F; Arcari A; Tabanelli V;
SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort. in Hematological oncology / Hematol Oncol. 2023 Feb;41(1):128-138. doi: 10.1002/hon.3092. Epub 2022 Oct 25.
2023
ASL Torino 5
AO Alessandria
AO Cuneo
AOU Città della Salute di Torino
ASL Cuneo 1
AOU Novara
Corradini P; Cilloni D; Visani G; Federici AB; Tisi MC; Cudillo L; Galimberti S; Gherlinzoni F; Visco C; Bertù L; Pagano L; Guidetti A; Coviello E; Passamonti F; Bocchia M; Gentile M; Della Porta MG; Mohamed S; Mauro FR; Gambacorti-Passerini C; Massaia M; Billio A; Scattolin A; Marchesi F; Fracchiolla NS; Cattaneo C; Derenzini E; Arcaini L; Trentin L; et alii...
The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi. in Hematological oncology / Hematol Oncol. 2023 Feb;41(1):78-87. doi: 10.1002/hon.3081. Epub 2022 Oct 7.
2023
AO Alessandria
AOU Città della Salute di Torino
AOU Novara
Merli F; Bocchia M; Spina M; Marcheselli L; Mammi C; Daffini R; Nassi L; Tani M; Musurca G; Cavallo F; Al Essa W; Gini G; Sartori R; Merli M; Tafuri A; Zanni M; Botto B; Arcari A; Petrucci L; Zilioli VR; Balzarotti M; Marino D; Luminari S; Usai SV; Pennese E; Hohaus S; Fabbri A; Puccini B; Tucci A; et alii...
A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphoma. in Blood advances / Blood Adv. 2023 Aug 8;7(15):4160-4169. doi: 10.1182/bloodadvances.2023009839.
2023
AOU Città della Salute di Torino
AOU Novara
AO Alessandria
Merli F; Spina M; Bernuzzi P; Mammi C; Marcheselli L; Tabanelli V; Ferrero S; Cencini E; Nassi L; Dessì D; Vallisa D; Pagani C; Hohaus S; Tarantini G; Flenghi L; Tani M; Di Rocco A; Merli M; Gini G; Zanni M; Musuraca G; Marino D; Sartori R; Botto B; Mahmoud AM; Balzarotti M; Pelliccia S; Luminari S; Pennese E; et alii...
Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCL. in Blood advances / Blood Adv. 2023 Aug 8;7(15):3916-3924. doi: 10.1182/bloodadvances.2023009744.
2023
AOU Città della Salute di Torino
AOU Novara
AO Alessandria
Tisi MC; Moia R; Visco C; Arcari A; Merli F; Stelitano C; Re A; Volpetti S; Zilioli VR; Pileri SA; Quaglia FM; Ferrante M; Bruna R; Di Rocco A; Chini C; Ghiggi C; Zambello R; Zanni M; Sciarra R; Celli M; Puccini B; Cencini E; Tani M; Botto B; Spina M; Ferrero S; Evangelista A; Patti C;
Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi. in HemaSphere / Hemasphere. 2023 Apr 4;7(4):e837. doi: 10.1097/HS9.0000000000000837. eCollection 2023 Apr.
2023
AOU Città della Salute di Torino
AOU Novara
Ferretti VV; Ricardi U; Arcaini L; Ferrari S; Lazic T; Cristinelli C; Gotti M; Sciarra R; Pulsoni A; Merli F; Luminari S; Zerbi C; Trentin L; Pagani C; Dalceggio D; Pravato S; Visentin A; Alvarez I; Del Giudice I; D'Elia GM; Zoboli V; Annechini G; Tartaglia G; Bonfichi M; Filippi AR; Fabbri A; Liberati AM; Merli M; Nassi L; et alii...
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study. in Blood advances / Blood Adv. 2022 Jan 11;6(1):327-338. doi: 10.1182/bloodadvances.2021005691.
2022
ASL Torino 5
ASL Biella
AO Cuneo
AOU Città della Salute di Torino
ASL Cuneo 1
AOU Novara
AO Alessandria
Bertù L; Ladetto M; Pilerci S; Pinto A; Ramadan S; Marchesi F; Cavo M; Visco C; Romano A; Coviello E; Merli F; Passamonti F; Krampera M; Corradini P; Candoni A; Conconi A; Tosi P; Lanza F; Venditti A; Selleri C; Vallisa D; Visani G; Gambacorti-Passerini C; La Barbera EO; Rigacci L; Armiento D; Cilloni D; Corso A; Cardinali V; et alii...
HBV Reactivation in Patients with Past Infection Affected by Non-Hodgkin Lymphoma and Treated with Anti-CD20 Antibody Based Immuno-Chemotherapy: A Multicenter Experience. in Journal of personalized medicine / J Pers Med. 2022 Feb 15;12(2):285. doi: 10.3390/jpm12020285.
2022
AO Cuneo
AOU Città della Salute di Torino
AOU Novara
De Luca G; Peri V; Ferrero S; Cervi L; Ragaini S; Al Essa W; Battaglini M; Cavallo F; Grimaldi D; Botto B; Ghione P; Zilioli VR; Merli F; Dogliotti I; Clerico M; Marzano A;
COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies. in British journal of haematology / Br J Haematol. 2021 Nov;195(3):371-377. doi: 10.1111/bjh.17704. Epub 2021 Jul 16.
2021
ASL Torino 5
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
AOU Novara
Pagano L; Corradini P; Bertù L; Petrucci L; Zaja F; Grossi PA; Musto P; Visani G; Lanza F; Cattaneo C; La Barbera EO; Mina R; Cardinali V; Galimberti S; Luppi M; Krampera M; Fracchiolla N; Bocchia M; Candoni A; Armiento D; Arcaini L; Tafuri A; Busca A; Marchesi F; Pinto A; Massaia M; Ladetto M; Venditti A; Cairoli R; et alii...
A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial. in Cancers / Cancers (Basel). 2021 Dec 31;14(1):188. doi: 10.3390/cancers14010188.
2021
AO Alessandria
AOU Città della Salute di Torino
AOU Novara
Ladetto M; Cortelazzo S; Dreyling M; Kluin-Nelemans HC; Hermine O; Vitolo U; Fabbri A; Latte G; Guarini A; Patti C; Pascarella A; Vallisa D; Spina M; Merli F; Di Renzo N; Cabras MG; Volpetti S; Tani M; Moia R; Del Giudice I; Barbero D; Genuardi E; Ghislieri M; Drandi D; Evangelista A; Passera R; Hoster E; Ferrero S; Zaccaria GM; et alii...
Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2021 Apr 10;39(11):1214-1222. doi: 10.1200/JCO.20.02465. Epub 2021 Feb 12.
2021
AOU Città della Salute di Torino
AOU Novara
Spina M; Mammi C; Chimienti E; Marcheselli L; Tarantini G; Molinari A; Flenghi L; Kovalchuk S; Re F; Bottelli C; Tani M; Musuraca G; Di Rocco A; Nassi L; Lleshi A; Botto B; Hohaus S; Merli M; Sartori R; Gini G; Balzarotti M; Cox MC; Zanni M; Marino D; Zilioli VR; Pennese E; Ferrari A; Cencini E; Delamain MT; et alii...
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. in The Lancet. Haematology / Lancet Haematol. 2020 Oct;7(10):e737-e745. doi: 10.1016/S2352-3026(20)30251-9. Epub 2020 Aug 13.
2020
AO Alessandria
ASL Biella
AOU Città della Salute di Torino
ASL Torino 5
AOU Novara
Grossi PA; Corradini P; Pagano L; Corrao G; Bertù L; Franchi M; Visco C; Rigacci L; Armiento D; Pane F; Oberti M; Zappasodi P; Galieni P; Fava C; Candoni A; Venditti A; Pinto A; Marchesi F; Musto P; Federici AB; Olivieri A; Gentile M; Bocchia M; Selleri C; Ortu La Barbera E; Ferrandina C; Di Renzo N; Luppi M; Scattolin AM; et alii...
Nonpeghylated liposomal doxorubicin combination regimen (R-COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity. in Hematological oncology / Hematol Oncol. 2020 Oct;38(4):478-486. doi: 10.1002/hon.2764. Epub 2020 Jul 9.
2020
AOU Città della Salute di Torino
AOU Novara
Zinzani PL; Santoro A; Mamusa AM; Cox C; Scalzulli R; Margiotta-Casaluci G; Bolis S; Spina M; Merli F; Luminari S; Broggi S; Pozzi S; Vitolo U; Angrilli F; Bonifacio E; Pregnolato F; Kovalchuk S; Annibali O; Rigacci L; Ferrari S; Gini G; Vigliotti ML; Mulè A; Flenghi L;
Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana Linfomi. in Journal of geriatric oncology / J Geriatr Oncol. 2020 Jan;11(1):37-40. doi: 10.1016/j.jgo.2019.06.020. Epub 2019 Jul 8.
2020
ASL Biella
AOU Città della Salute di Torino
AOU Novara
Luminari S; Mammi C; Zanni M; Conconi A; Matteucci P; Bari A; Scalone R; Ferrero S; Ferrari A; Molinari AL; Liberati AM; Tani M; Gini G; Merli M; Nassi L; Tucci A; Salvi F; Musuraca G; Cavallo F; Merli F;
Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (?70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL). in Leukemia & lymphoma / Leuk Lymphoma. 2019 Dec;60(12):2890-2898. doi: 10.1080/10428194.2019.1608529. Epub 2019 Jul 8.
2019
ASL Torino 4
AOU Città della Salute di Torino
AOU Novara
Evangelista A; Peli A; Volpetti S; Pavone V; Pulsoni A; Arcari A; Tani M; Patti C; Nassi L; Musuraca G; Freilone R; Centurioni R; Re A; Zanni M; Stelitano C; Liberati AM; Massidda S; Tucci A; Luminari S; Salvi F; Spina M; Ladetto M; Merli F;
Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) score. in Bone marrow transplantation / Bone Marrow Transplant. 2018 Apr;53(4):461-473. doi: 10.1038/s41409-017-0051-y. Epub 2018 Jan 12.
2018
AO Alessandria
AOU Novara
Di Nardo E; Saraceni F; Milone G; Pastore D; Specchia G; Lanza F; Codeluppi K; Mele G; Merli F; Capria S; Musto P; Marktel S; Mengarelli A; Ciceri F; Zallio F; Pini M; Moscato T; Martino M; Pioltelli PE; Piccirillo N; Sica S; Nassi L; Gaidano G; Farina L; Corradini P; Poiani M; Pascale SP; Chiarucci M; Nuccorini R; et alii...
Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study. in The Lancet. Oncology / Lancet Oncol. 2017 Aug;18(8):1076-1088. doi: 10.1016/S1470-2045(17)30444-8. Epub 2017 Jun 28.
2017
AOU Città della Salute di Torino
AOU Novara
Tucci A; Cabras MG; Congiu AG; Gotti M; Castellino A; Russo E; Cascavilla N; D'Arco A; Zaja F; Rigacci L; Pavone V; Gaidano G; Merli F; Balzarotti M; Rossi G; Stelitano C; Carella AM; Evangelista A; Brusamolino E; Angelucci E; Martelli M; Chiappella A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U;
The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study. in Haematologica / Haematologica. 2015 Apr;100(4):517-24. doi: 10.3324/haematol.2014.108183. Epub 2015 Jan 16.
2015
AOU Novara
Rossi D; Bruscaggin A; La Cava P; Galimberti S; Ciabatti E; Luminari S; Rigacci L; Tucci A; Pulsoni A; Bertoldero G; Vallisa D; Rusconi C; Spina M; Arcaini L; Angrilli F; Stelitano C; Merli F; Gaidano G; Federico M; Palumbo GA;
Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2014 Jul;25(7):1404-1410. doi: 10.1093/annonc/mdu166. Epub 2014 May 5.
2014
AO Alessandria
AOU Novara
Pulsoni A; Baldini L; Mancuso S; Marino D; Bruno R; Rossi D; Spedini P; Rigacci L; Levis A; Musto P; Ladetto M; Merli F; d'Arco A; Stelitano C; Tucci M; Luminari S; Visco C; Cabras G; Spina M; Tucci A; Rusconi C; Varettoni M; Ambrosetti A; Chiappella A; Merli M; Bernuzzi P; Ferreri AJM; Ferretti VV; Rattotti S; et alii...